ID   RETR2_HUMAN             Reviewed;         543 AA.
AC   Q8NC44; Q6P1P5; Q9H0K7;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-JUN-2023, entry version 145.
DE   RecName: Full=Reticulophagy regulator 2 {ECO:0000312|HGNC:HGNC:28450};
GN   Name=RETREG2 {ECO:0000312|HGNC:HGNC:28450};
GN   Synonyms=C2orf17, FAM134A, MAG2 {ECO:0000312|HGNC:HGNC:28450};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-419.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 262-543, AND VARIANT GLN-419.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 431-543.
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311 AND SER-385, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-279; SER-281 AND SER-283,
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-419, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-344 AND SER-347, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-291; SER-311; SER-347 AND
RP   SER-385, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   INTERACTION WITH MAP1LC3A; MAP1LC3B; GABARAP AND GABARAPL1, AND DOMAIN.
RX   PubMed=26040720; DOI=10.1038/nature14498;
RA   Khaminets A., Heinrich T., Mari M., Grumati P., Huebner A.K., Akutsu M.,
RA   Liebmann L., Stolz A., Nietzsche S., Koch N., Mauthe M., Katona I.,
RA   Qualmann B., Weis J., Reggiori F., Kurth I., Huebner C.A., Dikic I.;
RT   "Regulation of endoplasmic reticulum turnover by selective autophagy.";
RL   Nature 522:354-358(2015).
RN   [16]
RP   FUNCTION, INTERACTION WITH MAP1LC3A; MAP1LC3B; MAP1LC3C; GABARAP;
RP   GABARAPL1; GABARAPL2 AND CANX, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   492-PHE--LEU-495.
RX   PubMed=34338405; DOI=10.15252/embr.202052289;
RA   Reggio A., Buonomo V., Berkane R., Bhaskara R.M., Tellechea M., Peluso I.,
RA   Polishchuk E., Di Lorenzo G., Cirillo C., Esposito M., Hussain A.,
RA   Huebner A.K., Huebner C.A., Settembre C., Hummer G., Grumati P., Stolz A.;
RT   "Role of FAM134 paralogues in endoplasmic reticulum remodeling, ER-phagy,
RT   and Collagen quality control.";
RL   EMBO Rep. 22:e52289-e52289(2021).
RN   [17]
RP   INTERACTION WITH GABARAPL1 AND MAP1LC3B.
RX   PubMed=34854256; DOI=10.1002/2211-5463.13340;
RA   Zhao J., Li Z., Li J.;
RT   "The crystal structure of the FAM134B-GABARAP complex provides mechanistic
RT   insights into the selective binding of FAM134 to the GABARAP subfamily.";
RL   FEBS Open Bio 12:320-331(2022).
CC   -!- FUNCTION: Endoplasmic reticulum (ER)-anchored autophagy regulator which
CC       exists in an inactive state under basal conditions but is activated
CC       following cellular stress (PubMed:34338405). When activated, induces ER
CC       fragmentation and mediates ER delivery into lysosomes through
CC       sequestration into autophagosomes via interaction with ATG8 family
CC       proteins (PubMed:34338405). Required for collagen quality control in a
CC       LIR motif-independent manner (By similarity).
CC       {ECO:0000250|UniProtKB:Q6NS82, ECO:0000269|PubMed:34338405}.
CC   -!- SUBUNIT: Interacts with ATG8 family modifier proteins MAP1LC3A,
CC       MAP1LC3B, MAP1LC3C, GABARAP, GABARAPL1 and GABARAPL2 (PubMed:26040720,
CC       PubMed:34338405, PubMed:34854256). Shows higher affinity for GABARAPL1
CC       than for MAP1LC3B (PubMed:34854256). Interacts with CANX
CC       (PubMed:34338405). {ECO:0000269|PubMed:26040720,
CC       ECO:0000269|PubMed:34338405, ECO:0000269|PubMed:34854256}.
CC   -!- INTERACTION:
CC       Q8NC44; Q9GZQ8: MAP1LC3B; NbExp=2; IntAct=EBI-712899, EBI-373144;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:34338405}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- DOMAIN: The LIR motif interacts with ATG8 family proteins.
CC       {ECO:0000269|PubMed:26040720, ECO:0000269|PubMed:34338405}.
CC   -!- SIMILARITY: Belongs to the RETREG family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK074983; BAC11332.1; -; mRNA.
DR   EMBL; AC068946; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC064950; AAH64950.1; -; mRNA.
DR   EMBL; AL136758; CAB66692.2; -; mRNA.
DR   CCDS; CCDS2434.1; -.
DR   RefSeq; NP_077269.3; NM_024293.5.
DR   PDB; 6EWC; X-ray; 3.20 A; C/G=400-408.
DR   PDBsum; 6EWC; -.
DR   AlphaFoldDB; Q8NC44; -.
DR   SMR; Q8NC44; -.
DR   BioGRID; 122558; 50.
DR   DIP; DIP-56781N; -.
DR   IntAct; Q8NC44; 31.
DR   MINT; Q8NC44; -.
DR   STRING; 9606.ENSP00000395249; -.
DR   iPTMnet; Q8NC44; -.
DR   PhosphoSitePlus; Q8NC44; -.
DR   BioMuta; RETREG2; -.
DR   DMDM; 296439357; -.
DR   EPD; Q8NC44; -.
DR   jPOST; Q8NC44; -.
DR   MassIVE; Q8NC44; -.
DR   MaxQB; Q8NC44; -.
DR   PaxDb; Q8NC44; -.
DR   PeptideAtlas; Q8NC44; -.
DR   ProteomicsDB; 72849; -.
DR   Antibodypedia; 2502; 45 antibodies from 16 providers.
DR   DNASU; 79137; -.
DR   Ensembl; ENST00000430297.7; ENSP00000395249.2; ENSG00000144567.11.
DR   GeneID; 79137; -.
DR   KEGG; hsa:79137; -.
DR   MANE-Select; ENST00000430297.7; ENSP00000395249.2; NM_024293.6; NP_077269.3.
DR   UCSC; uc002vjw.5; human.
DR   AGR; HGNC:28450; -.
DR   CTD; 79137; -.
DR   DisGeNET; 79137; -.
DR   GeneCards; RETREG2; -.
DR   HGNC; HGNC:28450; RETREG2.
DR   HPA; ENSG00000144567; Low tissue specificity.
DR   neXtProt; NX_Q8NC44; -.
DR   OpenTargets; ENSG00000144567; -.
DR   PharmGKB; PA162386165; -.
DR   VEuPathDB; HostDB:ENSG00000144567; -.
DR   eggNOG; ENOG502QPTN; Eukaryota.
DR   GeneTree; ENSGT00940000162511; -.
DR   HOGENOM; CLU_036265_2_1_1; -.
DR   InParanoid; Q8NC44; -.
DR   OMA; EKWKPRF; -.
DR   OrthoDB; 5400903at2759; -.
DR   PhylomeDB; Q8NC44; -.
DR   TreeFam; TF329111; -.
DR   PathwayCommons; Q8NC44; -.
DR   SignaLink; Q8NC44; -.
DR   BioGRID-ORCS; 79137; 8 hits in 1155 CRISPR screens.
DR   ChiTaRS; FAM134A; human.
DR   GenomeRNAi; 79137; -.
DR   Pharos; Q8NC44; Tdark.
DR   PRO; PR:Q8NC44; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q8NC44; protein.
DR   Bgee; ENSG00000144567; Expressed in sperm and 196 other tissues.
DR   ExpressionAtlas; Q8NC44; baseline and differential.
DR   Genevisible; Q8NC44; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0140506; F:endoplasmic reticulum-autophagosome adaptor activity; IEA:Ensembl.
DR   GO; GO:0030574; P:collagen catabolic process; IEA:Ensembl.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; IEA:Ensembl.
DR   GO; GO:0061709; P:reticulophagy; IEA:Ensembl.
DR   CDD; cd22561; RETR2_RHD; 1.
DR   PANTHER; PTHR20952; ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN; 1.
DR   PANTHER; PTHR20952:SF4; RETICULOPHAGY REGULATOR 2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autophagy; Endoplasmic reticulum; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..543
FT                   /note="Reticulophagy regulator 2"
FT                   /id="PRO_0000089346"
FT   TRANSMEM        12..32
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        100..120
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        204..224
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          254..287
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          336..394
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          411..486
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          504..543
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           490..495
FT                   /note="LIR motif"
FT                   /evidence="ECO:0000305|PubMed:26040720"
FT   COMPBIAS        336..350
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        462..478
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         279
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         311
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         334
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NS82"
FT   MOD_RES         337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NS82"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         385
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18088087, ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   VARIANT         374
FT                   /note="R -> H (in dbSNP:rs3210652)"
FT                   /id="VAR_033720"
FT   VARIANT         419
FT                   /note="P -> Q (in dbSNP:rs3731900)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0007744|PubMed:18669648"
FT                   /id="VAR_022835"
FT   MUTAGEN         492..495
FT                   /note="FELL->AELA: Abolishes interaction with ATG8 family
FT                   proteins, induction of ER fragmentation and ER
FT                   degradation."
FT                   /evidence="ECO:0000269|PubMed:34338405"
FT   CONFLICT        338
FT                   /note="E -> G (in Ref. 1; BAC11332)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   543 AA;  57830 MW;  03DD659722BA9E5B CRC64;
     MASGGGGGNT GAGGGPGMGL SLGLGLGLSL GMSEATSEAE EEAATAEAVG RLATTLWLRL
     RGWEAVLAAA QRLLVWEKPL HSLVTAAALN GLFWLLSSSS LRPFFLLSVS LLAYFLLDLW
     QPRFLPDVSA SSPEEPHSDS EGAGSGARPH LLSVPELCRY LAESWLTFQI HLQELLQYKR
     QNPAQFCVRV CSGCAVLAVL GHYVPGIMIS YIVLLSILLW PLVVYHELIQ RMYTRLEPLL
     MQLDYSMKAE ANALHHKHDK RKRQGKNAPP GGDEPLAETE SESEAELAGF SPVVDVKKTA
     LALAITDSEL SDEEASILES GGFSVSRATT PQLTDVSEDL DQQSLPSEPE ETLSRDLGEG
     EEGELAPPED LLGRPQALSR QALDSEEEEE DVAAKETLLR LSSPLHFVNT HFNGAGSPPD
     GVKCSPGGPV ETLSPETVSG GLTALPGTLS PPLCLVGSDP APSPSILPPV PQDSPQPLPA
     PEEEEALTTE DFELLDQGEL EQLNAELGLE PETPPKPPDA PPLGPDIHSL VQSDQEAQAV
     AEP
//
